Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apyx Medical Corporation stock logo
APYX
Apyx Medical
$2.16
-3.6%
$1.50
$0.76
$2.30
$81.64M1.2181,307 shs54,013 shs
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
$3.76
+3.9%
$2.82
$1.60
$16.55
$279.10M1.091.08 million shs4.16 million shs
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$13.18
+1.0%
$16.65
$12.76
$27.28
$125.40M1.1386,013 shs1.50 million shs
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$4.30
+1.2%
$3.60
$2.03
$8.45
$222.29M2.46212,697 shs840,410 shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apyx Medical Corporation stock logo
APYX
Apyx Medical
0.00%+8.00%+35.00%+66.15%+60.00%
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
0.00%+8.67%+39.26%+70.91%-60.46%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
0.00%-0.90%-31.10%-34.95%-41.81%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
0.00%+5.91%+22.16%+68.63%-31.96%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apyx Medical Corporation stock logo
APYX
Apyx Medical
2.428 of 5 stars
0.05.00.04.22.21.70.6
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3.164 of 5 stars
4.61.00.00.03.02.50.0
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
4.8843 of 5 stars
3.51.00.84.93.83.32.5
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
1.1461 of 5 stars
1.13.00.00.02.03.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apyx Medical Corporation stock logo
APYX
Apyx Medical
2.67
Moderate BuyN/AN/A
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3.18
Buy$12.56233.92% Upside
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
3.00
Buy$26.0097.27% Upside
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
2.29
Hold$4.10-4.65% Downside

Current Analyst Ratings Breakdown

Latest APYX, LAKE, CATX, and SGHT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $12.00
6/23/2025
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$11.00
6/18/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$3.50 ➝ $4.00
6/10/2025
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$30.00 ➝ $26.00
6/3/2025
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeOutperform ➝ Moderate Buy$15.00 ➝ $16.00
5/22/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$3.20 ➝ $3.60
5/14/2025
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$10.00 ➝ $8.00
5/13/2025
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform$11.00
5/9/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$2.50 ➝ $3.00
4/15/2025
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$28.00 ➝ $23.00
4/9/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apyx Medical Corporation stock logo
APYX
Apyx Medical
$48.10M1.70N/AN/A$0.38 per share5.68
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
$1.43M195.17N/AN/A$2.67 per share1.41
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$167.21M0.75$1.07 per share12.35$15.07 per share0.87
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$79.87M2.78N/AN/A$1.72 per share2.50
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apyx Medical Corporation stock logo
APYX
Apyx Medical
-$23.46M-$0.55N/AN/AN/A-42.37%-156.85%-31.92%8/6/2025 (Estimated)
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
-$46.51MN/A0.00N/AN/A-4,096.66%-27.40%-23.16%8/11/2025 (Estimated)
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-$18.08M-$3.01N/A7.94N/A-13.31%-6.88%-4.47%9/3/2025 (Estimated)
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$51.51M-$0.98N/AN/AN/A-63.24%-54.62%-34.92%7/30/2025 (Estimated)

Latest APYX, LAKE, CATX, and SGHT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/9/2025Q1 2026
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.27-$0.41-$0.68-$0.41$48.84 million$46.75 million
5/8/2025Q1 2025
Apyx Medical Corporation stock logo
APYX
Apyx Medical
-$0.13-$0.10+$0.03-$0.10$9.39 million$9.43 million
5/8/2025Q1 2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$0.29-$0.28+$0.01-$0.28$16.51 million$17.51 million
4/9/2025Q4 2025
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.43-$0.54-$0.97-$2.42$47.10 million$46.60 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apyx Medical Corporation stock logo
APYX
Apyx Medical
N/AN/AN/AN/AN/A
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
N/AN/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.120.91%N/AN/A 1 Years
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
N/AN/AN/AN/AN/A

Latest APYX, LAKE, CATX, and SGHT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
quarterly$0.030.71%5/15/20255/15/20255/22/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apyx Medical Corporation stock logo
APYX
Apyx Medical
3.21
5.45
4.64
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
N/A
9.60
9.60
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
0.17
3.88
1.51
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
0.51
10.47
9.99

Institutional Ownership

CompanyInstitutional Ownership
Apyx Medical Corporation stock logo
APYX
Apyx Medical
55.33%
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
54.66%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
71.69%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
55.51%

Insider Ownership

CompanyInsider Ownership
Apyx Medical Corporation stock logo
APYX
Apyx Medical
16.80%
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
3.72%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
1.91%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
30.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Apyx Medical Corporation stock logo
APYX
Apyx Medical
27037.79 million31.45 millionOptionable
Perspective Therapeutics, Inc. stock logo
CATX
Perspective Therapeutics
7074.23 million65.21 millionOptionable
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
2,1009.51 million9.33 millionOptionable
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
21051.70 million35.72 millionOptionable

Recent News About These Companies

Sight Sciences (NASDAQ:SGHT) Upgraded to Hold at Wall Street Zen
Sight Sciences Leads The Pack Of 3 Promising Penny Stocks
Sight Sciences appoints new board member

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Apyx Medical stock logo

Apyx Medical NASDAQ:APYX

$2.16 -0.08 (-3.57%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$2.17 +0.01 (+0.46%)
As of 06/27/2025 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Perspective Therapeutics stock logo

Perspective Therapeutics NYSE:CATX

$3.76 +0.14 (+3.87%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$3.81 +0.05 (+1.36%)
As of 06/27/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. The company discovers, designs, and develop its initial programs candidates consists of VMT-a-NET, that is currently in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2) expressing tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta-emitting therapy; and VMT01, which is currently in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma. Perspective Therapeutics, Inc. has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Lakeland Industries stock logo

Lakeland Industries NASDAQ:LAKE

$13.18 +0.13 (+1.00%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$13.15 -0.03 (-0.23%)
As of 06/27/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.

Sight Sciences stock logo

Sight Sciences NASDAQ:SGHT

$4.30 +0.05 (+1.18%)
Closing price 06/27/2025 04:00 PM Eastern
Extended Trading
$4.30 0.00 (0.00%)
As of 06/27/2025 04:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.